Loading...

Radiation Therapy as a Bridging Strategy for CAR T Cell Therapy With Axicabtagene Ciloleucel in Diffuse Large B-Cell Lymphoma

PURPOSE: Axicabtagene ciloleucel (axi-cel) is a CD19-directed chimeric antigen receptor (CAR) T-cell therapy for relapsed or refractory diffuse large B-cell lymphoma. Bridging therapy may be required for lymphoma control during the manufacturing interval between collection of autologous T cells and...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Int J Radiat Oncol Biol Phys
Main Authors: Sim, Austin J., Jain, Michael D., Figura, Nicholas B., Chavez, Julio C., Shah, Bijal D., Khimani, Farhad, Lazaryan, Aleksandr, Krivenko, Gabriel, Davila, Marco L., Liu, Hien D., Falchook, Aaron D., Dahiya, Saurabh, Rapoport, Aaron P., Kim, Sungjune, Locke, Frederick L., Robinson, Timothy J.
Format: Artigo
Sprog:Inglês
Udgivet: 2019
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6872916/
https://ncbi.nlm.nih.gov/pubmed/31175906
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijrobp.2019.05.065
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!